Implementation intention training for prospective memory in schizophrenia: A 3-month follow-up study.


Journal

Schizophrenia research
ISSN: 1573-2509
Titre abrégé: Schizophr Res
Pays: Netherlands
ID NLM: 8804207

Informations de publication

Date de publication:
04 2019
Historique:
received: 12 06 2018
revised: 10 10 2018
accepted: 20 10 2018
pubmed: 28 10 2018
medline: 18 6 2020
entrez: 28 10 2018
Statut: ppublish

Résumé

The beneficial effect of implementation intentions (II) on prospective memory (PM) deficits in patients with schizophrenia has been reported. However, these studies were limited to brief interventions such that the transfer and long-term effects of II training remains unclear. This study examined whether a 10-session II programme could improve PM performance, social functioning and functional capacity in patients with schizophrenia immediately after training and at 3-month follow-up. Patients with schizophrenia (n = 42) recruited from the community were randomly assigned to II training (n = 21) or treatment as usual (TAU) (n = 21). Participants in the II group learned the verbal and imagery component of II and were encouraged to apply these strategies in their daily lives. We found that the II group performed better than the TAU group on computer-based PM tasks and a daily life PM task (telephone call at specified date and time) at post-treatment and at 3-month follow-up. The II group also exhibited better working ability than the TAU group at post-treatment. Our results suggest that the II intervention programme may have lasting beneficial effects in PM performance and significant transfer effects to functional capacity in schizophrenia patients.

Identifiants

pubmed: 30366712
pii: S0920-9964(18)30617-0
doi: 10.1016/j.schres.2018.10.015
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

378-385

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Tao Chen (T)

Neuropsychology and Applied Cognitive Neuroscience Lab, CAS Key Laboratory of Mental Health, Institute of Psychology, Beijing, China; Department of Psychology, University of Chinese Academy of Sciences, Beijing, China.

Lu-Lu Liu (LL)

Menzies Health Institute Queensland, School of Applied Psychology, Griffith University, Gold Coast, Australia.

Ji-Fang Cui (JF)

Information Centre, National Institute of Education Sciences, Beijing, China.

Ying Li (Y)

Neuropsychology and Applied Cognitive Neuroscience Lab, CAS Key Laboratory of Mental Health, Institute of Psychology, Beijing, China; Department of Psychology, University of Chinese Academy of Sciences, Beijing, China.

Xiao-Jing Qin (XJ)

Neuropsychology and Applied Cognitive Neuroscience Lab, CAS Key Laboratory of Mental Health, Institute of Psychology, Beijing, China; Department of Psychology, University of Chinese Academy of Sciences, Beijing, China.

Shu-Li Tao (SL)

Community Health Service Center, College Road, Haidian District, Beijing, China.

David L Neumann (DL)

Menzies Health Institute Queensland, School of Applied Psychology, Griffith University, Gold Coast, Australia.

David H K Shum (DHK)

Department of Rehabilitation Sciences, Hong Kong Polytechnic University, Hong Kong, China; Neuropsychology and Applied Cognitive Neuroscience Lab, CAS Key Laboratory of Mental Health, Institute of Psychology, Beijing, China; Menzies Health Institute Queensland, School of Applied Psychology, Griffith University, Gold Coast, Australia.

Eric F C Cheung (EFC)

Castle Peak Hospital, Hong Kong, China.

Ya Wang (Y)

Neuropsychology and Applied Cognitive Neuroscience Lab, CAS Key Laboratory of Mental Health, Institute of Psychology, Beijing, China; Department of Psychology, University of Chinese Academy of Sciences, Beijing, China. Electronic address: wangya@psych.ac.cn.

Raymond C K Chan (RCK)

Neuropsychology and Applied Cognitive Neuroscience Lab, CAS Key Laboratory of Mental Health, Institute of Psychology, Beijing, China; Department of Psychology, University of Chinese Academy of Sciences, Beijing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH